SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Mostrar otras versiones (1)

Correction to: British Journal of Cancer (2002) 87, 630–634. doi:10.1038/sj.bjc.6600511

Detalles Bibliográficos
Autores principales: Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394240/
http://dx.doi.org/10.1038/sj.bjc.6601020
_version_ 1782155371573411840
author Boulay, J-L
Mild, G
Lowy, A
Reuter, J
Lagrange, M
Terracciano, L
Laffer, U
Herrmann, R
Rochlitz, C
author_facet Boulay, J-L
Mild, G
Lowy, A
Reuter, J
Lagrange, M
Terracciano, L
Laffer, U
Herrmann, R
Rochlitz, C
author_sort Boulay, J-L
collection PubMed
description Correction to: British Journal of Cancer (2002) 87, 630–634. doi:10.1038/sj.bjc.6600511
format Text
id pubmed-2394240
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23942402009-09-10 SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer Boulay, J-L Mild, G Lowy, A Reuter, J Lagrange, M Terracciano, L Laffer, U Herrmann, R Rochlitz, C Br J Cancer Erratum Correction to: British Journal of Cancer (2002) 87, 630–634. doi:10.1038/sj.bjc.6600511 Nature Publishing Group 2003-07-21 2003-07-15 /pmc/articles/PMC2394240/ http://dx.doi.org/10.1038/sj.bjc.6601020 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Erratum
Boulay, J-L
Mild, G
Lowy, A
Reuter, J
Lagrange, M
Terracciano, L
Laffer, U
Herrmann, R
Rochlitz, C
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
title SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
title_full SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
title_fullStr SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
title_full_unstemmed SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
title_short SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
title_sort smad4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394240/
http://dx.doi.org/10.1038/sj.bjc.6601020
work_keys_str_mv AT boulayjl smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT mildg smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT lowya smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT reuterj smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT lagrangem smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT terraccianol smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT lafferu smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT herrmannr smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer
AT rochlitzc smad4isapredictivemarkerfor5fluorouracilbasedchemotherapyinpatientswithcolorectalcancer

Ejemplares similares